The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Regulatory T cells and treatment of cancer
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
Self-citationCalreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Liu, W., Putnam, A. L., Xu-yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., de St. Groth, B. F., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060772 · Cited by 2,606
Regulatory T cells, tumour immunity and immunotherapy
Zou, W. (2006) · Nature Reviews Immunology · doi:10.1038/nri1806 · Cited by 2,085
Immunosuppressive networks in the tumour environment and their therapeutic relevance
Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057
Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor
Quintana, F. J., Basso, A. S., Iglesias, A. H., Korn, T., Farez, M. F., Bettelli, E., Caccamo, M., Oukka, M., & Weiner, H. L. (2008) · Nature · doi:10.1038/nature06880 · Cited by 1,865
Deacetylase inhibition promotes the generation and function of regulatory T cells
Tao, R., de Zoeten, E. F., Özkaynak, E., Chen, C., Wang, L., Porrett, P. M., Li, B., Turka, L. A., Olson, E. N., Greene, M. I., et al. (2007) · Nature Medicine · doi:10.1038/nm1652 · Cited by 924
Sharma, M. D., Baban, B., Chandler, P., Hou, D.-Y., Singh, N., Yagita, H., Azuma, M., Blazar, B. R., Mellor, A. L., & Munn, D. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31911 · Cited by 792
B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma
Kryczek, I., Zou, L., Rodriguez, P., Zhu, G., Wei, S., Mottram, P., Brumlik, M., Cheng, P., Curiel, T., Myers, L., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050930 · Cited by 748 · cited 1×
“Tumor microenvironmental IL-6 and IL-10 induce B7-H4+ macrophages that suppress tumor-specific immunity as do Tregs [21].”
BackgroundSelf-citationTregs and rethinking cancer immunotherapy
Curiel, T. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31202 · Cited by 547
Self-citationTumor-Specific Human CD4+ Regulatory T Cells and Their Ligands
Wang, H. Y., Lee, D. A., Peng, G., Guo, Z., Li, Y., Kiniwa, Y., Shevach, E. M., & Wang, R.-F. (2004) · Immunity · doi:10.1016/s1074-7613(03)00359-5 · Cited by 515
Strauss, L., Bergmann, C., Szczepanski, M., Gooding, W., Johnson, J. T., & Whiteside, T. L. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0472 · Cited by 453
Liu, V. C., Wong, L. Y., Jang, T., Shah, A. H., Park, I., Yang, X., Zhang, Q., Lonning, S., Teicher, B. A., & Lee, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2883 · Cited by 453
Tzankov, A., Meier, C., Hirschmann, P., Went, P., Pileri, S. A., & Dirnhofer, S. (2008) · Haematologica · doi:10.3324/haematol.11702 · Cited by 412
Regulatory T-cell inhibition versus depletion: the right choice in cancer immunotherapy
Colombo, M. P., & Piconese, S. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2250 · Cited by 407
OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection
Piconese, S., Valzasina, B., & Colombo, M. P. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071341 · Cited by 405
Curti, A., Pandolfi, S., Valzasina, B., Aluigi, M., Isidori, A., Ferri, E., Salvestrini, V., Bonanno, G., Rutella, S., Durelli, I., et al. (2007) · Blood · doi:10.1182/blood-2006-07-036863 · Cited by 396
Welters, M. J. P., Kenter, G. G., Piersma, S. J., Vloon, A. P. G., Löwik, M. J. G., Berends-van der Meer, D. M. A., Drijfhout, J. W., Valentijn, A. R. P. M., Wafelman, A. R., Oostendorp, J., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1880 · Cited by 373
Control of Immune Responses by Antigen-Specific Regulatory T Cells Expressing the Folate Receptor
Yamaguchi, T., Hirota, K., Nagahama, K., Ohkawa, K., Takahashi, T., Nomura, T., & Sakaguchi, S. (2007) · Immunity · doi:10.1016/j.immuni.2007.04.017 · Cited by 357
CD8+ Foxp3+ Regulatory T Cells Mediate Immunosuppression in Prostate Cancer
Kiniwa, Y., Miyahara, Y., Wang, H. Y., Peng, W., Peng, G., Wheeler, T. M., Thompson, T. C., Old, L. J., & Wang, R.-F. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0842 · Cited by 352
Juszczynski, P., Ouyang, J., Monti, S., Rodig, S. J., Takeyama, K., Abramson, J., Chen, W., Kutok, J. L., Rabinovich, G. A., & Shipp, M. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706017104 · Cited by 327
Vitamin A Metabolites Induce Gut-Homing FoxP3+ Regulatory T Cells
Kang, S. G., Lim, H. W., Andrisani, O. M., Broxmeyer, H. E., & Kim, C. H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3724 · Cited by 311
Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines
Zhou, G., Drake, C. G., & Levitsky, H. I. (2006) · Blood · doi:10.1182/blood-2005-07-2737 · Cited by 272
Mantel, P.-Y., Kuipers, H., Boyman, O., Rhyner, C., Ouaked, N., Rückert, B., Karagiannidis, C., Lambrecht, B. N., Hendriks, R. W., Crameri, R., et al. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050329 · Cited by 268
Regulatory T Cells in Ovarian Cancer: Biology and Therapeutic Potential
Barnett, B., Kryczek, I., Cheng, P., Zou, W., & Curiel, T. J. (2005) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2005.00330.x · Cited by 233
Self-citationLarmonier, N., Marron, M., Zeng, Y., Cantrell, J., Romanoski, A., Sepassi, M., Thompson, S., Chen, X., Andreansky, S., & Katsanis, E. (2006) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-006-0160-8 · Cited by 225
Zhou, G., & Levitsky, H. I. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2155 · Cited by 213
Yang, Z.-Z., Novak, A. J., Ziesmer, S. C., Witzig, T. E., & Ansell, S. M. (2007) · Blood · doi:10.1182/blood-2007-03-082578 · Cited by 206
Tumor-Infiltrating Foxp3−CD4+CD25+ T Cells Predict Poor Survival in Renal Cell Carcinoma
Siddiqui, S. A., Frigola, X., Bonne-Annee, S., Mercader, M., Kuntz, S. M., Krambeck, A. E., Sengupta, S., Dong, H., Cheville, J. C., Lohse, C. M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2139 · Cited by 202
Taming cancer by inducing immunity via dendritic cells
Palucka, A. K., Ueno, H., Fay, J. W., & Banchereau, J. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00575.x · Cited by 189
Litzinger, M. T., Fernando, R., Curiel, T. J., Grosenbach, D. W., Schlom, J., & Palena, C. (2007) · Blood · doi:10.1182/blood-2007-06-094615 · Cited by 188
Self-citationCirculating tumor antigen-specific regulatory T cells in patients with metastatic melanoma
Vence, L., Palucka, A. K., Fay, J. W., Ito, T., Liu, Y.-J., Banchereau, J., & Ueno, H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710557105 · Cited by 175
Powell, D. J., Felipe-Silva, A., Merino, M. J., Ahmadzadeh, M., Allen, T., Levy, C., White, D. E., Mavroukakis, S., Kreitman, R. J., Rosenberg, S. A., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4919 · Cited by 166
Song, X.-T., Kabler, K. E., Shen, L., Rollins, L., Huang, X. F., & Chen, S.-Y. (2008) · Nature Medicine · doi:10.1038/nm1721 · Cited by 163
A Pilot Study of CTLA-4 Blockade after Cancer Vaccine Failure in Patients with Advanced Malignancy
O’Mahony, D., Morris, J. C., Quinn, C., Gao, W., Wilson, W. H., Gause, B. L., Pittaluga, S., Neelapu, S. S., Brown, M. R., Fleisher, T. A., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1974 · Cited by 162
Pallandre, J., Brillard, E., Créhange, G., Radlovic, A., Rémy-Martin, J.-P., Saas, P., Rohrlich, P., Pivot, X. B., Ling, X., Tiberghien, P., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7593 · Cited by 161
Wei, S., Kryczek, I., Edwards, R. P., Zou, L., Szeliga, W., Banerjee, M., Cost, M., Cheng, P., Chang, A., Redman, B., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0565 · Cited by 159
Yokokawa, J., Cereda, V., Remondo, C., Gulley, J. L., Arlen, P. M., Schlom, J., & Tsang, K. Y. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2056 · Cited by 155
Bergmann, C., Strauss, L., Zeidler, R., Lang, S., & Whiteside, T. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0767 · Cited by 153
Vaccination against the Forkhead Family Transcription Factor Foxp3 Enhances Tumor Immunity
Nair, S. K., Boczkowski, D., Faßnacht, M., Pisetsky, D. S., & Gilboa, E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2903 · Cited by 150
Kurooka, M., & Kaneda, Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1615 · Cited by 143
Molling, J. W., de Gruijl, T. D., Glim, J. E., Moreno, M., Rozendaal, L., Meijer, C. J. L. M., van den Eertwegh, A. J. M., Scheper, R. J., von Blomberg, M. E., & Bontkes, H. J. (2007) · International Journal of Cancer · doi:10.1002/ijc.22894 · Cited by 138
Liu, J.-Y., Wu, Y., Zhang, X.-S., Yang, J.-L., Li, H.-L., Mao, Y.-Q., Wang, Y., Cheng, X., Li, Y.-Q., Xia, J., et al. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0305-4 · Cited by 134
Local and systemic induction of CD4+CD25+ regulatory T-cell population by non-Hodgkin lymphoma
Mittal, S., Marshall, N. A., Duncan, L., Culligan, D. J., Barker, R. N., & Vickers, M. A. (2008) · Blood · doi:10.1182/blood-2007-08-105395 · Cited by 131
Molenkamp, B. G., van Leeuwen, P. A. M., Meijer, S., Sluijter, B. J. R., Wijnands, P. G. J. T. B., Baars, A., van den Eertwegh, A. J. M., Scheper, R. J., & de Gruijl, T. D. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0050 · Cited by 131
Mizukami, Y., Kono, K., Kawaguchi, Y., Akaike, H., Kamimura, K., Sugai, H., & Fujii, H. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604149 · Cited by 130
A simple but effective cancer vaccine consisting of an antigen and a cationic lipid
Chen, W., Yan, W., & Huang, L. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0390-4 · Cited by 127
Kelley, T. W., Pohlman, B. L., Elson, P. J., & Hsi, E. D. (2007) · American Journal of Clinical Pathology · doi:10.1309/nb3947k383dj0lq2 · Cited by 116
Battaglia, A., Buzzonetti, A., Monego, G., Peri, L., Ferrandina, G., Fanfani, F., Scambia, G., & Fattorossi, A. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02737.x · Cited by 115
Regulatory T‐cell function of adult T‐cell leukemia/lymphoma cells
Yano, H., Ishida, T., Inagaki, A., Ishii, T., Kusumoto, S., Komatsu, H., Iida, S., Utsunomiya, A., & Ueda, R. (2007) · International Journal of Cancer · doi:10.1002/ijc.22536 · Cited by 96
Kato, Y., Yoshimura, K., Shin, T., Verheul, H. M. W., Hammers, H. J., Sanni, T. B., Salumbides, B. C., van Erp, K., Schulick, R. D., & Пили, Р. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0014 · Cited by 92
Ahonen, C. L., Wasiuk, A., Fuse, S., Turk, M. J., Ernstoff, M. S., Suriawinata, A. A., Gorham, J. D., Kedl, R. M., Usherwood, E. J., & Noelle, R. J. (2008) · Blood · doi:10.1182/blood-2007-09-114371 · Cited by 86
van der Vliet, H. J., Koon, H. B., Yue, S. C., Uzunparmak, B., Seery, V. J., Gavin, M. A., Rudensky, A. Y., Atkins, M. B., Balk, S. P., & Exley, M. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1662 · Cited by 77
Molecular and Cellular Mechanisms of Photocarcinogenesis†
Beissert, S., & Loser, K. (2007) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2007.00231.x · Cited by 74
Zabala, M., Lasarte, J. J., Perret, C., Sola, J., Berraondo, P., Alfaro, M., Larrea, E., Prìeto, J., & Kramer, M. G. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.07.025 · Cited by 71
The impact of regulatory T cells on carcinogen-induced sarcogenesis
Betts, G. J., Twohig, J. P., van den Broek, M. F., Sierro, S. R., Godkin, A. J., & Gallimore, A. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603824 · Cited by 71
Melanoma Induces Immunosuppression by Up-Regulating FOXP3+ Regulatory T Cells
Baumgartner, J. M., Wilson, C. C., Palmer, B. E., Richter, D. A., Banerjee, A. M., & McCarter, M. D. (2007) · Journal of Surgical Research · doi:10.1016/j.jss.2007.03.053 · Cited by 71
Poutahidis, T., Haigis, K. M., Rao, V. P., Nambiar, P. R., Taylor, C. L., Ge, Z., Watanabe, K., Davidson, A., Horwitz, B. H., Fox, J. G., et al. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm180 · Cited by 68
Rüter, J., Barnett, B. G., Kryczek, I., Brumlik, M. J., Daniel, B. J., Coukos, G., Zou, W., & Curiel, T. J. (2009) · Frontiers in bioscience · doi:10.2741/3338 · Cited by 66
Self-citationPowell, D. J., de Vries, C. R., Allen, T., Ahmadzadeh, M., & Rosenberg, S. A. (2007) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3180600ff9 · Cited by 59
Regulatory T-cell development: is Foxp3 the decider?
Curiel, T. J. (2007) · Nature Medicine · doi:10.1038/nm0307-250 · Cited by 57
Self-citationLi, X., Ye, F., Chen, H., Lü, W., Wan, X., & Xie, X. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.01.024 · Cited by 45
Tumor Cells Expressing Anti-CD137 scFv Induce a Tumor-Destructive Environment
Yang, Y., Yang, S., Ye, Z., Jaffar, J., Zhou, Y., Cutter, E., Lieber, A., Hellström, I., & Hellström, K. E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3593 · Cited by 45
Li, B., Saouaf, S. J., Samanta, A., Shen, Y., Hancock, W. W., & Greene, M. I. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.07.006 · Cited by 32
Nitcheu-Tefit, J., Dai, M., Critchley-Thorne, R. J., Ramirez-Jimenez, F., Xu, M., Conchon, S., Ferry, N., Stauss, H. J., & Vassaux, G. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1532 · Cited by 32
Kakinuma, T., Nadiminti, H., Lonsdorf, A. S., Murakami, T., Perez, B. A., Kobayashi, H., Finkelstein, S. E., Pothiawala, G., Belkaid, Y., & Hwang, S. T. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0253-4 · Cited by 16
Berhanu, A., Huang, J. J., Watkins, S. C., Okada, H., & Storkus, W. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3400 · Cited by 9
Manipulating T regulatory cells in cancer immunotherapy
Rüter, J., Barnett, B. G., Kryczek, I., Brumlik, M. J., Daniel, B. J., Coukos, G., Zou, W., & Curiel, T. J. (2006) · Expert Review of Dermatology · doi:10.1586/17469872.1.4.589 · Cited by 3
Self-citation
Cited by
Tumour necrosis factor and cancer
Balkwill, F. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2628 · Cited by 1,915
Natural and Adaptive Foxp3+ Regulatory T Cells: More of the Same or a Division of Labor?
Curotto de Lafaille, M. A., & Lafaille, J. J. (2009) · Immunity · doi:10.1016/j.immuni.2009.05.002 · Cited by 1,055
Molecular Mechanisms of Treg-Mediated T Cell Suppression
Schmidt, A., Oberle, N., & Krammer, P. H. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00051 · Cited by 761
Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer
Ali, K., Soond, D. R., Piñeiro, R., Hagemann, T., Pearce, W., Lim, E. L., Bouabe, H., Scudamore, C. L., Hancox, T., Maecker, H., et al. (2014) · Nature · doi:10.1038/nature13444 · Cited by 529
Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity
Ostrand-Rosenberg, S. (2010) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-010-0855-8 · Cited by 521
Metadata
- Authors
- Curiel, T. J.
- Venue
- Current Opinion in Immunology
- Publisher
- Elsevier BV
- Published
- 2008-04
- Volume
- 20
- Issue
- 2
- Pages
- 241-246
- ISSN
- 0952-7915 (ISSN-L)
- OpenAlex
- W1977955576
- Cited by
- 262
- References
- 68
- FWCI
- 1.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.